论文部分内容阅读
近日,在日本札幌举行的“第43届动脉粥样硬化年会”上,cluster randomized usual care vs caduet investigation assessing long-termrisk(CRUCIAL)研究亚太人群亚组结果公布了。研究结果显示:在高血压合并3个以上心血管危险因素的高血压患者中,在常规降压基础上加用氨氯地平/阿托伐他汀单片药,即采用降压联合他汀的治疗方案,可明显降低高血压患者未来心血管风险。CRUCIAL研究是一项国际大型全球多中心临床
Recently, the results of the Asia-Pacific Population Sub-group were released at the 43rd Annual Meeting of the Society of Atherosclerosis in Sapporo, Japan, where the cluster randomized usual care vs caduet investigation assessing long-termrisk (CRUCIAL) study was conducted. The results show that: in hypertensive patients with hypertension more than three cardiovascular risk factors in patients with conventional blood pressure based on the use of amlodipine / atorvastatin monotherapy, the use of antihypertensive therapy combined with statin , Can significantly reduce the future cardiovascular risk of hypertensive patients. The CRUCIAL study is an international large-scale global multicenter clinic